1-(6-Amino-9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)-9H-Purin-2-Yl)-N-Methyl-1H-Pyrazole-4-Carboxamide 1-(6-氨基-9-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-9H-嘌呤-2-基)-N-甲基-1H-吡唑-4-甲酰胺
CAS 313348-27-5 MFCD09832544
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Nucleotides
- Bases & Related Reagents
- Pharmaceuticals
- Intermediates & Fine Chemicals,
产品应用
- A selective A2A adenosine receptor agonist in myocardial imaging.
相关文献及参考
- [2]. Golzar Y, et al. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge. Int J Chron Obstruct Pulmon Dis. 2014;9:129-137. Published 2014 Jan 22.
- [3]. Jackson S, et al. The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study. J Neurooncol. 2017;132(3):513-519.
- Gordi, T., et al.: J. Clin. Pharmacol., 47, 825 (2007),
- Palle, V.P., et al.: J. A. Drug Dev. Res., 50, 64 (2000),
- [1]. Palle VP, et al. Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. Bioorg Med Chem Lett. 2002;12(20):2935-2939.
- [1]. Palle VP, et al. Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. Bioorg Med Chem Lett. 2002;12(20):2935-2939.
- [2]. Golzar Y, et al. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current